HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Mathilde Varret Selected Research
Mathilde Varret Research Topics
Disease
26
Hyperlipoproteinemia Type II (Familial Hypercholesterolemia)
09/2023 - 08/2002
6
Cardiovascular Diseases (Cardiovascular Disease)
01/2023 - 11/2005
6
Hypercholesterolemia
05/2022 - 11/2005
6
Coronary Disease (Coronary Heart Disease)
12/2021 - 06/2003
5
Dyslipidemias (Dyslipidemia)
12/2023 - 12/2016
3
Atherosclerosis
12/2023 - 02/2015
3
Familial Combined Hyperlipidemia (Combined Hyperlipidemia, Familial)
05/2022 - 01/2013
3
Inborn Genetic Diseases (Disease, Hereditary)
03/2022 - 01/2003
2
Stroke (Strokes)
12/2021 - 10/2018
2
Thoracic Aortic Aneurysm
01/2021 - 12/2014
2
Hyperlipoproteinemia Type III (Broad Beta Disease)
01/2021 - 01/2013
2
Coronary Artery Disease (Coronary Atherosclerosis)
02/2015 - 03/2013
1
Homozygous Familial Hypercholesterolemia
01/2023
1
Hyperlipoproteinemia Type I (Lipoprotein Lipase Deficiency, Familial)
01/2022
1
Non-alcoholic Fatty Liver Disease
01/2022
1
Inflammation (Inflammations)
12/2021
1
Infarction (Infarctions)
12/2021
1
Aortic Valve Stenosis (Aortic Stenosis)
12/2021
1
Hypobetalipoproteinemias (Hypobetalipoproteinemia)
08/2021
1
Chronic Obstructive Pulmonary Disease (COPD)
01/2021
1
Lipoprotein Glomerulopathy
01/2021
1
Abetalipoproteinemia (Bassen Kornzweig Syndrome)
01/2019
1
Myocardial Infarction
10/2018
1
Unstable Angina
10/2018
1
Type 2 Diabetes Mellitus (MODY)
01/2018
1
Sea-Blue Histiocyte Syndrome (Sea Blue Histiocytosis)
01/2013
1
Primary Hypertrophic Osteoarthropathy (Hypertrophic Osteoarthropathy, Primary)
08/2012
1
Primary Myelofibrosis (Myelosclerosis)
08/2012
1
Chylomicron retention disease
01/2011
1
Malabsorption Syndromes (Malabsorption Syndrome)
01/2011
1
Xanthomatosis (Xanthoma)
05/2010
1
Diffuse Scleroderma (Progressive Systemic Sclerosis)
04/2010
1
Systemic Scleroderma (Systemic Sclerosis)
02/2009
1
Genetic Predisposition to Disease (Genetic Predisposition)
02/2009
1
Marfan Syndrome (Marfan's Syndrome)
08/2004
1
Neoplasms (Cancer)
08/2004
1
3 Autosomal Dominant Hypercholesterolemia
06/2003
Drug/Important Bio-Agent (IBA)
13
Apolipoproteins B (ApoB)
IBA
01/2023 - 01/2003
13
LDL Cholesterol
IBA
01/2023 - 06/2003
11
LDL Receptors (LDL Receptor)
IBA
09/2023 - 08/2002
11
Apolipoproteins
IBA
08/2021 - 01/2003
10
Proprotein Convertase 9
IBA
09/2023 - 06/2003
8
Cholesterol
IBA
12/2021 - 11/2005
7
Apolipoproteins E (ApoE)
IBA
12/2023 - 01/2013
7
oxidized low density lipoprotein
IBA
09/2023 - 11/2005
6
LDL Lipoproteins (beta Lipoproteins)
IBA
03/2013 - 04/2009
5
Lipids
IBA
01/2023 - 01/2011
5
Proprotein Convertases (Pro-Opiomelanocortin Converting Enzyme)
IBA
12/2016 - 07/2009
4
Triglycerides (Triacylglycerol)
IBA
05/2022 - 01/2013
4
Subtilisin
IBA
12/2016 - 11/2010
3
Lipoproteins (Lipoprotein)
IBA
01/2022 - 01/2019
2
1,3,4,6- tetra- O- acetyl- 2- azido- 2- deoxyglucopyranose (TAAD)
IBA
01/2021 - 12/2014
2
Prostaglandins
IBA
01/2021 - 08/2012
2
Proteins (Proteins, Gene)
FDA Link
01/2021 - 01/2011
2
Apolipoprotein B-100 (Apo B 100)
IBA
12/2012 - 05/2012
2
Ligands
IBA
07/2009 - 04/2009
1
Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)
IBA
09/2023
1
Chylomicrons
IBA
01/2022
1
Streptozocin (Streptozotocin)
FDA Link
12/2021
1
Antifibrinolytic Agents (Antifibrinolytics)
IBA
12/2021
1
Lipoprotein(a)
IBA
12/2021
1
Ephrin-B2 (Ephrin B2)
IBA
12/2021
1
Apolipoprotein E2
IBA
01/2021
1
Cyclooxygenase 2 (Cyclooxygenase-2)
IBA
01/2021
1
Prostaglandin D2
IBA
01/2021
1
Interleukin-18 (Interleukin 18)
IBA
01/2021
1
O(4)-methylthymidine triphosphate
IBA
01/2019
1
microsomal triglyceride transfer protein
IBA
01/2019
1
Antibodies
IBA
10/2017
1
PCSK9 Inhibitors
IBA
12/2016
1
Fibrillin-1
IBA
04/2010
1
subtilin
IBA
07/2009
1
Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)
IBA
02/2009
1
F 382
IBA
11/2005
1
Transforming Growth Factor beta Receptors (TGF beta Receptors)
IBA
08/2004
1
Transforming Growth Factor-beta Type II Receptor
IBA
08/2004
1
Fibrillins
IBA
08/2004
Therapy/Procedure
2
Therapeutics
10/2017 - 12/2016
1
Bariatric Surgery
01/2022
1
Electrocoagulation (Electrocautery)
12/2021
1
Percutaneous Coronary Intervention
10/2018